The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and meta-analysis.
Expert Rev Vaccines
; 21(10): 1455-1464, 2022 10.
Article
in English
| MEDLINE | ID: covidwho-1927219
ABSTRACT
OBJECTIVES:
We systematically reviewed the literature to investigate the pooled effect of COVID-19 mRNA vaccination against SARS-CoV-2 infection and its clinical outcomes.METHODS:
Scopus, Web of Science, PubMed (Medline), and Embase were searched on 9 September 2021. The odds ratio (OR) of COVID-19 infection and its clinical outcomes in fully/ partially vaccinated versus unvaccinated participants were calculated and pooled by using a random-effects model.RESULTS:
The pooled analysis showed that among health care workers and general population, vaccinated participants with one or two doses were less likely to infect with SARS-CoV-2 (OR = 0.16; 95%CI 0.08-0.32; I2 = 79.86%; 95%CI I2 68.99-87.21%), to develop symptomatic COVID-19 infection (OR = 0.09; 95%CI 0.03-0.32; I2 = 80.43%; 95%CI I2 70.83-89.33%), to admit to the hospital because of COVID-19 (OR = 0.13; 95%CI 0.06-0.28; I2 = 86.19%; 95%CI I2 67.80-93.88%), and to die from COVID-19 (OR = 0.14; 95%CI 0.06-0.35; I2 = 66.76%; 95%CI I2 54.00-76.99%) than unvaccinated participants.CONCLUSIONS:
COVID-19 mRNA vaccines, especially following administration of two doses, are extremely effective. It would be suggested further studies with large sample size and different ethnicities to be conducted among the general population to warrant these results.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Expert Rev Vaccines
Journal subject:
Allergy and Immunology
Year:
2022
Document Type:
Article
Affiliation country:
14760584.2022.2102001
Similar
MEDLINE
...
LILACS
LIS